Error in record details...
- | ||||||||||||||||||||||||||||
. ; (0): .
|
How to Cite this Article |
Pubmed Style Julie Mariam Joshua, Salima K D, Meenu Vijayan. Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report. Natl J Physiol Pharm Pharmacol. Online First: 07 Sep, 2017. doi:10.5455/njppp.2018.8.0724705082017 Web Style Julie Mariam Joshua, Salima K D, Meenu Vijayan. Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report. https://www.njppp.com/?mno=271913 [Access: March 16, 2024]. doi:10.5455/njppp.2018.8.0724705082017 AMA (American Medical Association) Style Julie Mariam Joshua, Salima K D, Meenu Vijayan. Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report. Natl J Physiol Pharm Pharmacol. Online First: 07 Sep, 2017. doi:10.5455/njppp.2018.8.0724705082017 Vancouver/ICMJE Style Julie Mariam Joshua, Salima K D, Meenu Vijayan. Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report. Natl J Physiol Pharm Pharmacol, [cited March 16, 2024]; Online First: 07 Sep, 2017. doi:10.5455/njppp.2018.8.0724705082017 Harvard Style Julie Mariam Joshua, Salima K D, Meenu Vijayan (2018) Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report. Natl J Physiol Pharm Pharmacol, Online First: 07 Sep, 2017. doi:10.5455/njppp.2018.8.0724705082017 Turabian Style Julie Mariam Joshua, Salima K D, Meenu Vijayan. 2018. Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report. National Journal of Physiology, Pharmacy and Pharmacology, Online First: 07 Sep, 2017. doi:10.5455/njppp.2018.8.0724705082017 Chicago Style Julie Mariam Joshua, Salima K D, Meenu Vijayan. "Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report." National Journal of Physiology, Pharmacy and Pharmacology Online First: 07 Sep, 2017. doi:10.5455/njppp.2018.8.0724705082017 MLA (The Modern Language Association) Style Julie Mariam Joshua, Salima K D, Meenu Vijayan. "Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report." National Journal of Physiology, Pharmacy and Pharmacology Online First: 07 Sep, 2017. Web. 16 Mar 2024 doi:10.5455/njppp.2018.8.0724705082017 APA (American Psychological Association) Style Julie Mariam Joshua, Salima K D, Meenu Vijayan (2018) Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report. National Journal of Physiology, Pharmacy and Pharmacology, Online First: 07 Sep, 2017. doi:10.5455/njppp.2018.8.0724705082017 |